Comparing The Efficacy And Safety Of Crocus Sativus L. With Memantine In Patients With Moderate To Severe Alzheimer's Disease: A Double-blind Randomized Clinical Trial
Notes for this study:
|Number of Subjects
In a randomized, double-blind, placebo-controlled trial, 68 participants with moderate to severe Alzheimer's disease took 30 mg of saffron extract or 20 mg of memantine daily for 12 months.
The primary outcome was score on the Severe Cognitive Impairment Rating Scale (SCIRS) and both groups saw a modest and comparable improvement over 12 months, though there wasn't a statistically significant difference from baseline. Score on the Functional Assessment Staging (FAST) saw an improvement and MiniMental State Examination also saw a comparable improvement.
The trial was preregistered: IRCT201203051556N39